Which Medtech Startups Will Take Part in the MedCity INVEST Pitch Perfect Contest?
The diagnostics/medical device track focuses on cardiology this year.
Realizing the Promise of Neuromelanin-Sensitive MRI (NM-MRI)
Routine NM-MRI for individuals at risk of Parkinson's could provide a means of identifying the disease before symptoms emerge.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
23andMe: What If …
A much diminished 23andMe exists today, a far cry from the phenomenon that it was in the world consumer DNA testing. Could things have unfolded differently under a different leader with a different vision?
FDA Announces Recall of Heart Pumps Linked to Deaths and Injuries
The recall comes years after surgeons say they first noticed problems with the HeartMate II and HeartMate 3, manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories. The devices are not currently being removed from the market.
Biolinq Snags $58M for ‘Smallest Biosensor in the World’
Biolinq raked in $58 million in capital this week. The company is developing a wearable patch that uses electrochemical sensors to measure a person’s glucose levels from the intradermal space just beneath the surface of their skin.
FDA Grants Its First-Ever Clearance for Sepsis Detection AI
Chicago-based Prenosis gained FDA clearance for its sepsis detection technology this week, marking the first time the agency has cleared an AI diagnostic tool for sepsis.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Eko Health Gains FDA Clearance For Cardiology Algorithm That Can Detect Heart Failure in 15 Seconds
This week, Eko Health received FDA clearance for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. The tool, which was developed in collaboration with Mayo Clinic, is embedded into Eko’s digital stethoscopes.
FDA Clears the First Digital Therapeutic for Depression, But Will Payers Cover It?
The Otsuka Pharmaceutical and Click Therapeutics mobile app Rejoyn received FDA clearance for use as an adjunct to medication in the treatment of major depressive disorder. But Otsuka must overcome hurdles facing digital therapeutics products, which have yet to gain traction among payers.
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
Novocure’s Electrical Cancer Therapy Shows It Can Treat Tumors in the Brain
Novocure said its “Tumor Treating Fields” met the main goal of a pivotal study enrolling non-small cell lung cancer patients with brain metastases. However, results for the electricty-based treatment fell short of statistical significance on several secondary endpoints.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
MedCity Pivot: A Conversation About Wearable Robots with Scott Davis
Scott Davis is the CEO of Ekso Bionics, an innovative medical device company making wearable exoskeletons for use in construction but perhaps, more importantly, to help people contending with spinal cord injury.
MedCity INVEST Pitch Perfect Judge Shares Healthcare Investment Perspective
David Kereiakes, managing partner with Windham Venture Partners, shared his perspective of the health tech sector and investment trends he's seeing.
Gonorrhea, Chlamydia and Syphilis Rates Are Exploding. Here’s How AI Can Help.
The emergence of artificial intelligence (AI) offers a glimmer of hope in the fight against STDs and has the power to revolutionize the landscape of STD detection, treatment, and prevention.
Philips, AWS Deepen Collaboration to Scale Digital Pathology in the Cloud
At HIMSS, Philips and AWS announced that they are expanding their collaboration with the goal of scaling digitized pathology slides in the cloud. The partners seek to help pathology labs better store and analyze vast volumes of data, as well as adopt more streamlined, cloud-based workflows to reduce clinician burnout.
Boutique Healthcare Investment Event MedCity INVEST Is Two Months Away. Register Today!
Join MedCity News and nearly 300 healthcare investors, startups, and innovative-minded executives in Chicago at the Ritz Carlton on May 21-22. Space is limited. Secure your spot today to attend!